Literature DB >> 31336167

Long-label-retaining mammary epithelial cells are created early in ductal development and distributed throughout the branching ducts.

Lauren E Ragle1, Robert D Bruno2, Corinne A Boulanger1, Gilbert H Smith3.   

Abstract

Long-label retention has been used by many to prove Cairns' immortal strand hypothesis and to identify potential stem cells. Here, we describe two strategies using 5-ethynl-2'-deoxyuridine (EdU) to identify and understand the distribution of long-label-retaining mammary epithelial cells during formation of the mouse mammary ductal system. First, EdU was given upon two consecutive days per week during weeks 4 through 10 and analyzed for label retention at 13 weeks of age. Alternatively, EdU was given for 14 consecutive days beginning at 28 days of age and ending at 42 days of age. Analyses were conducted at >91 days of age (13 weeks). Many more LREC were detected following the second labeling method and their distribution among the subsequently developed ducts. This finding indicated that the early-labeled cells that retained their label were distributed into portions of the gland that developed after the ending of EdU treatment (i.e. 42->91 days). These observations may have important meaning with respect to the previously demonstrated retention of regenerative capacity throughout the mouse mammary gland despite age or reproductive history. These results suggest LREC may represent long-lived progenitor cells that are responsible for mammary gland homeostasis. Additionally, these cells may act as multipotent stem cells capable of mammary gland regeneration upon random fragment transplantation into epithelium-denuded mammary fat pads. Published by Elsevier B.V.

Entities:  

Keywords:  Development; EDU-labeling; Long-label-retaining; Mammary; Stem cell

Mesh:

Year:  2019        PMID: 31336167      PMCID: PMC6759405          DOI: 10.1016/j.mod.2019.103565

Source DB:  PubMed          Journal:  Mech Dev        ISSN: 0925-4773            Impact factor:   1.882


  24 in total

1.  Mutation selection and the natural history of cancer.

Authors:  J Cairns
Journal:  Nature       Date:  1975-05-15       Impact factor: 49.962

Review 2.  The stem-cell niche theory: lessons from flies.

Authors:  Haifan Lin
Journal:  Nat Rev Genet       Date:  2002-12       Impact factor: 53.242

3.  Mammary stem cell repertoire: new insights in aging epithelial populations.

Authors:  Gilbert H Smith; Corinne A Boulanger
Journal:  Mech Ageing Dev       Date:  2002-09       Impact factor: 5.432

Review 4.  Steroid receptors and cell cycle in normal mammary epithelium.

Authors:  Elizabeth Anderson; Robert B Clarke
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-01       Impact factor: 2.673

5.  Interaction with the mammary microenvironment redirects spermatogenic cell fate in vivo.

Authors:  Corinne A Boulanger; David L Mack; Brian W Booth; Gilbert H Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-28       Impact factor: 11.205

6.  Sca-1(pos) cells in the mouse mammary gland represent an enriched progenitor cell population.

Authors:  Bryan E Welm; Stacey B Tepera; Teresa Venezia; Timothy A Graubert; Jeffrey M Rosen; Margaret A Goodell
Journal:  Dev Biol       Date:  2002-05-01       Impact factor: 3.582

7.  Label-retaining epithelial cells in mouse mammary gland divide asymmetrically and retain their template DNA strands.

Authors:  Gilbert H Smith
Journal:  Development       Date:  2005-01-12       Impact factor: 6.868

8.  Intestinal stem cells protect their genome by selective segregation of template DNA strands.

Authors:  Christopher S Potten; Gary Owen; Dawn Booth
Journal:  J Cell Sci       Date:  2002-06-01       Impact factor: 5.285

9.  Estrogen receptor-alpha and progesterone receptor are expressed in label-retaining mammary epithelial cells that divide asymmetrically and retain their template DNA strands.

Authors:  Brian W Booth; Gilbert H Smith
Journal:  Breast Cancer Res       Date:  2006       Impact factor: 6.466

10.  Selective segregation of DNA strands persists in long-label-retaining mammary cells during pregnancy.

Authors:  Brian W Booth; Corinne A Boulanger; Gilbert H Smith
Journal:  Breast Cancer Res       Date:  2008-10-24       Impact factor: 6.466

View more
  1 in total

Review 1.  Taking the road less traveled - the therapeutic potential of CBP/β-catenin antagonists.

Authors:  Michael Kahn
Journal:  Expert Opin Ther Targets       Date:  2021-10-27       Impact factor: 6.902

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.